CD34 and neoplasm: Meanwhile, the key components of the bone marrow niche, mesenchymal stem cells (CD45-Lin-CD34-c-kit-CD29+) and CXCL12 producing cells, were significantly decreased in the bone marrow of tumor-bearing mice (Figures 3B, C).